RxDoctor Payments Data

Sho Grant

Physician Assistant · Glendale, AZNPI 1245785732

Payments from drug & device makers

$7,476in general payments, 2019–2025

Across 263 payments — averaging $28.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$921
  • Antares Pharma, Inc.$860
  • Acerus Pharmaceuticals Corporation$447
  • Dendreon Pharmaceuticals LLC$418
  • Profound Medical Corp.$399
  • Verity Pharmaceuticals Inc.$350
  • plus $4K from 36 others

What the payments were for

  • Consulting fees$3505%
  • Food & beverage$6,95693%
  • Education$1702%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,476 in reported general payments places this provider in the 95th percentile of 2,888 physician assistant providers in Arizona.

See all physician assistant providers in Arizona

Medicare billing

Part B allowed, 2024
$70,914
Medicare patients
426
Services billed
1,584

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MyrbetriqMirabegron74$59,077
GemtesaVibegron54$44,069
XyostedTestosterone Enanthate49$30,154
Methenamine Hippurate46$3,339
Tamsulosin Hcl224$3,242
Finasteride203$1,987
Dutasteride45$1,660
Trimethoprim14$676
Oxybutynin Chloride17$483
Cefdinir30$353
Levofloxacin18$351
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst19$273
Oxybutynin Chloride ErOxybutynin Chloride17$218
Doxycycline Hyclate23$190
Ciprofloxacin Hcl43$145

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Astellas Pharma US IncMyrbetriq$238$59,07774 claims
Sumitomo Pharma America, Inc.Gemtesa$269$44,06954 claims
Antares Pharma, Inc.Xyosted$860$30,15449 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,888 physician assistant providers in Arizona.

Other physician assistant in Glendale

See the full list for Arizona

Where these figures come from

Is this you, or does something look wrong? →